A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD
A Multi-Center Randomized, Double-Blind, Parallel Group, Placebo Controlled Study, Including an Additional Open Label Tiotropium Group, to Assess the Efficacy, Safety and Tolerability of 4 Doses of AD 237 Inhaled Once Daily for 28 Days in Subjects With COPD.
1 other identifier
interventional
300
4 countries
33
Brief Summary
The purpose of this study is to investigate the efficacy, safety and tolerability of AD 237 in patients with chronic obstructive pulmonary disease (COPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
33 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 19, 2005
CompletedFirst Posted
Study publicly available on registry
October 20, 2005
CompletedMay 16, 2006
May 1, 2006
October 19, 2005
May 15, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary function
Secondary Outcomes (1)
Pulmonary function
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosed with COPD, with symptoms of cough and chronic sputum production and/or dyspnea.
- Post-bronchodilator FEV1 at no more than 65% and at least 30% of the predicted normal value.
- Pre-bronchodilator FEV1/FVC ratio of less than 70%.
- Current or ex-smokers with a smoking history of at least 10 pack years.
You may not qualify if:
- History of asthma, atopy or allergic rhinitis.
- Other serious respiratory or other medical conditions which may interfere with the outcome of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (33)
Specialized Hospital for Active Treatment Pneumophthysiatric Disease "Kudoglu"
Plovdiv, 4000, Bulgaria
Regional Dispensary for Pulmonary Diseases Rousse
Rousse, 7002, Bulgaria
5-th Multiprofile Hospital for Active Treatment
Sofia, 1233, Bulgaria
MHAT "Alexandrovska"
Sofia, 1431, Bulgaria
Specialized Hospital for Active Treatment of Pulmonary Diseases "Sveta Sofia"
Sofia, 1431, Bulgaria
Central Clinical Base - Medical Institute - Ministry of the Interior
Sofia, 1606, Bulgaria
Military Medical Academy
Sofia, 1606, Bulgaria
UMHAT "Stara Zagora" EAD
Stara Zagora, 6003, Bulgaria
University Hospital
Varna, 9010, Bulgaria
Tudogyintezete Nodradgardony
Balassagyarmat, 2661, Hungary
III. district Outpatient Clinic
Budapest, 1033, Hungary
Diagnostic Units Hungary Ltd
Budapest, 1036, Hungary
Gyogyir XI. Kht.II. Tudogondozo Intezet
Budapest, 1221, Hungary
Selye Janos Hospital
Komárom, 2900, Hungary
Karolona Hospital
Mosonmagyaróvár, 9200, Hungary
Szabolcs Szatmar Bereg Megyei Josa Andras Korhaz
Nyíregyháza, 4400, Hungary
Fejer County Szent Gyorgy Hospital
Székesfehérvár, 8001, Hungary
Vas County Markusovszky Hospital
Szombathely, 9700, Hungary
Szpital Wojewodzki
Bielsko-Biala, 43-316, Poland
10 Wojskowy Szpital Kliniczny Z Poliklinika
Bydgoszcz, 85-681, Poland
Samodzielny Publiczny Centralny Szpital Kliniczny SAM
Katowice, 40-752, Poland
Specjalistyczny Osrodek Alergologiczny ALL-MED
Krakow, 31-023, Poland
Barlicki University Hospital
Lodz, 90-153, Poland
Szpital ZOZ
Oława, 55-200, Poland
Wielkopolskie Centrum Chorob Pluc I Gruzlicy
Poznan, 60-569, Poland
Specjalistyczna Przychodnia Lekarska "Medikard"
Płock, 09-402, Poland
Spitalul Clinic de Urgenta Floreasca
Bucharest, 11641, Romania
Spitalul de Pneumo Ftiziologie "Sf. Stefan"
Bucharest, 20122, Romania
Spitalul Clinic "Colentina"
Bucharest, 20125, Romania
Institutul National de Boli Infectioase
Bucharest, 21105, Romania
Spitalul Clinic de Boli Infectioase si Tropicale " Dr. Victor Babes "
Bucharest, 30317, Romania
Institutul de Pneumologie " Marius Nasta "
Bucharest, 50159, Romania
Spitalul Clinic de Urgenta Constanta
Constanța, 900591, Romania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Robert G Tansley, MD
Arakis Ltd
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 19, 2005
First Posted
October 20, 2005
Study Start
October 1, 2005
Last Updated
May 16, 2006
Record last verified: 2006-05